Literature DB >> 15902970

Susceptibilities of p53 knockout and rasH2 transgenic mice to urethane-induced lung carcinogenesis are inherited from their original strains.

Masakazu Ozaki1, Keisuke Ozaki, Tomoyuki Watanabe, Satoshi Uwagawa, Yasuyoshi Okuno, Tomoyuki Shirai.   

Abstract

In the present study, susceptibility of CB6F1 mice carrying the human prototype c-Ha-ras gene (rasH2 mice) and p53 gene knockout mice (p53 (+/-) mice) to urethane-induced lung carcinogenesis was compared under the same experimental conditions. Both strains were administered 500 ppm urethane in their drinking water for 3 weeks. At week 26, lung adenocarcinomas and adenomas were observed in 53% and 100% of rasH2 mice, respectively, and lung adenomas were observed in 67% of rasH2 littermate (non-Tg) mice. However, lung tumors were not observed in either p53 (+/-) or p53 (+/+) mice. Peliosis hepatis and hepatic hemangiomas were observed in 27% and 67% of p53 (+/-) mice, but only in 6.7% and 6.7% of the rasH2 animals, respectively. Under the same experimental conditions, BALB/c mice, the strain of origin of the rasH2 mice, developed lung adenomas at an incidence of 93%, whereas none of the C57BL/6 original strain for p53 (+/-) mice developed lung tumors. Peliosis hepatis was observed in 40% of the C57BL/6 mice, but not in BALB/c mice; hepatic and splenic hemangiomas were not observed in these animals. These results indicate that organ susceptibility of rasH2 and p53 (+/-) mice is inherited from their strains of origin, the rasH2 and BALB/c lines being much more sensitive to the induction of pulmonary carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15902970     DOI: 10.1080/01926230590908231

Source DB:  PubMed          Journal:  Toxicol Pathol        ISSN: 0192-6233            Impact factor:   1.902


  1 in total

Review 1.  The use of genetically modified mice in cancer risk assessment: challenges and limitations.

Authors:  David A Eastmond; Suryanarayana V Vulimiri; John E French; Babasaheb Sonawane
Journal:  Crit Rev Toxicol       Date:  2013-09       Impact factor: 5.635

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.